CIS: Antisera Market 2024

Antisera Market Size in CIS

In 2022, the CIS antisera market decreased by X% to $X, falling for the second consecutive year after five years of growth. Over the period under review, consumption recorded a relatively flat trend pattern. As a result, consumption reached the peak level of $X. From 2021 to 2022, the growth of the market remained at a lower figure.

Antisera Production in CIS

In value terms, antisera production amounted to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% from 2012 to 2022; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. The level of production peaked at $X in 2020; afterwards, it flattened through to 2022.

Antisera Exports

Exports in CIS

In 2022, exports of antisera and other blood fractions in the CIS declined significantly to X tons, shrinking by X% against 2021. Overall, exports faced a abrupt descent. The growth pace was the most rapid in 2021 when exports increased by X%. As a result, the exports reached the peak of X tons, and then contracted notably in the following year.

In value terms, antisera exports dropped remarkably to $X in 2022. In general, exports continue to indicate a deep downturn. The pace of growth was the most pronounced in 2021 when exports increased by X%. As a result, the exports reached the peak of $X, and then shrank sharply in the following year.

Exports by Country

In 2022, Azerbaijan (X tons), distantly followed by Russia (X tons) and Armenia (X tons) represented the main exporters of antisera and other blood fractions, together achieving X% of total exports. Moldova (X tons) took a relatively small share of total exports.

From 2012 to 2022, the biggest increases were recorded for Azerbaijan (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) remains the largest antisera supplier in the CIS, comprising X% of total exports. The second position in the ranking was held by Armenia ($X), with a X% share of total exports. It was followed by Azerbaijan, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Russia totaled X%. In the other countries, the average annual rates were as follows: Armenia (X% per year) and Azerbaijan (X% per year).

Export Prices by Country

In 2022, the export price in the CIS amounted to $X per ton, waning by X% against the previous year. Over the period under review, the export price recorded a pronounced descent. The pace of growth appeared the most rapid in 2014 when the export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2015 to 2022, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Russia ($X per ton), while Azerbaijan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Moldova (X%), while the other leaders experienced mixed trends in the export price figures.

Antisera Imports

Imports in CIS

In 2022, supplies from abroad of antisera and other blood fractions decreased by X% to X tons, falling for the second year in a row after five years of growth. Overall, imports saw a deep contraction. The pace of growth was the most pronounced in 2020 with an increase of X%. As a result, imports reached the peak of X tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, antisera imports shrank notably to $X in 2022. In general, imports faced a deep slump. The pace of growth was the most pronounced in 2019 when imports increased by X% against the previous year. Over the period under review, imports reached the maximum at $X in 2021, and then dropped remarkably in the following year.

Imports by Country

Russia was the largest importer of antisera and other blood fractions in the CIS, with the volume of imports reaching X tons, which was approx. X% of total imports in 2022. Kazakhstan (X tons) took the second position in the ranking, distantly followed by Uzbekistan (X tons) and Azerbaijan (X tons). All these countries together held near X% share of total imports. Kyrgyzstan (X tons), Armenia (X tons) and Tajikistan (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Uzbekistan (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X), Kazakhstan ($X) and Uzbekistan ($X) constituted the countries with the highest levels of imports in 2022, with a combined X% share of total imports.

Among the main importing countries, Uzbekistan, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in the CIS amounted to $X per ton, falling by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2021 when the import price increased by X%. As a result, import price reached the peak level of $X per ton, and then declined in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Kazakhstan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kyrgyzstan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :